This investigation is designed to evaluate the performance rate of two polyurethane male condoms with different sizes and thicknesses versus a standard natural rubber latex (NRL) male condom. The purpose of this study is to see how well the experimental condoms perform compared to the latex rubber condom (for example, how often the different condom types break or slip off the penis). Sponsor also wants to find out how well couples like using the three condom types and whether they experience any problems when using the condoms (for example, irritation or discomfort).
In this clinical investigation, new two PU male condoms (test condoms) will be evaluated against a marketed NRL male condom (control condom). This clinical investigation will also evaluate the in-use tolerance of the test and control condoms.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
600
A minimum of 5 condoms (maximum 7 condoms) of each condom type will be provided to couples to be used during vaginal intercourse over a maximum 5-week period (assessment period). Couples will repeat the assessment period for each of the 3 condom types.
A minimum of 5 condoms (maximum 7 condoms) of each condom type will be provided to couples to be used during vaginal intercourse over a maximum 5-week period (assessment period). Couples will repeat the assessment period for each of the 3 condom types.
A minimum of 5 condoms (maximum 7 condoms) of each condom type will be provided to couples to be used during vaginal intercourse over a maximum 5-week period (assessment period). Couples will repeat the assessment period for each of the 3 condom types.
Essential Access Health-Berkeley
Berkeley, California, United States
RECRUITINGEssential Access Health -Los Angeles
Los Angeles, California, United States
RECRUITINGEssential Acess Health- Seattle
Seattle, Washington, United States
RECRUITINGTotal clinical failure rate of Polyurethane (PU) male (Test condom 1) condom compared to Natural Rubber Latex (NRL) male condom.
The total clinical failure rate (combined breakage and slippage) of PU male test condom (Test condom 1) compared to the NRL male control condom. Clinical failure rate is calculated as the number of condoms with at least 1 acute clinical failure event divided by the number of condoms used during intercourse, reported as a percentage. Clinical failure events, defined in ISO 29943-1:2017, will be reported by participants.
Time frame: within 8 hours following each coital act for each condom use
Total clinical failure rate of Polyurethane (PU) male (Test condom 2) condom compared to Natural Rubber Latex (NRL) male condom.
The total clinical failure rate (combined breakage and slippage) of PU male test condom (Test condom 2) compared to the NRL male control condom. Clinical failure rate is calculated as the number of condoms with at least 1 acute clinical failure event divided by the number of condoms used during intercourse, reported as a percentage. Clinical failure events, defined in ISO 29943-1:2017, will be reported by participants.
Time frame: within 8 hours following each coital act for each condom use
Clinical breakage rate of PU Male Test Condom 1 compared to NRL male control condom
The total clinical breakage rate of the PU male test condom (Test condom 1) compared to the NRL male control condom when used during vaginal intercourse. The total clinical breakage rate is determined from the number of condoms broken or torn during vaginal intercourse or withdrawal from the vagina divided by the number of condoms used during intercourse, reported as a percentage.
Time frame: within 8 hours following each coital act for each condom use
Clinical slippage rate of PU Male Test Condom 1 compared to NRL male control condom
The total clinical slippage rate of the PU male test condom (Test condom 1) compared to the NRL male control condom when used during vaginal intercourse. The total clinical slippage rate is determined from the number of condoms that slipped completely off the penis during intercourse or withdrawal from the vagina, divided by the number of condoms used during vaginal intercourse, reported as a percentage.
Time frame: within 8 hours following each coital act for each condom use
Clinical breakage rate of PU Male Test Condom 2 compared to NRL male control condom
The total clinical breakage rate of the PU male test condom (Test condom 2) compared to the NRL male control condom when used during vaginal intercourse. The total clinical breakage rate is determined from the number of condoms broken or torn during vaginal intercourse or withdrawal from the vagina divided by the number of condoms used during intercourse, reported as a percentage.
Time frame: within 8 hours following each coital act for each condom use
Clinical slippage rate of PU Male Test Condom 2 compared to NRL male control condom
The total clinical slippage rate of the PU male test condom (Test condom 2) compared to the NRL male control condom when used during vaginal intercourse. The total clinical slippage rate is determined from the number of condoms that slipped completely off the penis during intercourse or withdrawal from the vagina, divided by the number of condoms used during vaginal intercourse, reported as a percentage.
Time frame: within 8 hours following each coital act for each condom use
Non-clinical breakage rate for each of the PU male condoms (test condom 1 and test condom 2) and the NRL male control condom.
The total non-clinical breakage rate for each of the PU male test condom and the NRL male control condom when used during vaginal intercourse. The total non-clinical breakage rate is determined from the number of condoms that tear during handling.
Time frame: within 8 hours following each coital act for each condom use
Non-clinical slippage respectively of each PU male test condom (test condom 1 and test condom 2) and the NRL male control condom.
The total non-clinical slippage rate for each of the PU male test condoms and the NRL male control condom when used during vaginal intercourse. The total non-clinical slippage rate is determined from the number of observations where the user fails to hold onto the condom at the base of the penis during withdrawal and/ or because the user delayed withdrawal after sex.
Time frame: within 8 hours following each coital act for each condom use
User acceptability of the 2 PU male test condoms (test condom 1 and test condom 2) and the NRL male control condom.
User acceptability, experience, and preference for each condom type will be evaluated through participant-perceived questions. Participant's experience on the use of each type of condoms \[Acceptability as assessed by participant perceived questionnaires (designed by following ISO 29943-1)
Time frame: within 8 hours following each coital act for each condom use
In-use tolerability of the 2 PU male test condoms (test condom 1 and test condom 2) and the NRL male control condom.
The in-use tolerability of each condom type will be evaluated through participant-perceived questions (designed by following ISO 29943-1).
Time frame: 5 weeks for each condom type
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.